VSEE HEALTH, INC. (VSEE): debt financing — VSee Health issues $217K convertible note at 18% interest, $0.48 conversion price, plus 50K shares

VSEE HEALTH, INC.

Initial principal $217,391; net proceeds $201,000 (8% OID) to VSee Health from M2B Funding Corp.
Interest 18% p.a.; first 8 months guaranteed; maturity Oct 29, 2026.
Conversion at $0.48/share after Jan 29, 2026; prepayment allowed with 10% fee.
Note secured by all company assets; investor has right to buy additional note for 12 months.
50,000 shares of common stock issued to investor for $1,000 as Additional Equity Stock.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

VSEE HEALTH, INC. incurred convertible notes of $217,391 with an accredited institutional investor at 18% per annum maturing October 29, 2026.

Instrument: convertible notes
Principal: $217,391
Counterparty: an accredited institutional investor
Rate: 18% per annum
Maturity: October 29, 2026
Event: incurrence

Exact text from the filing

On October 29, 2025, VSee Health, Inc. (the "Company"), entered into a convertible note purchase agreement (the "CNPA") with an accredited institutional investor (the "Investor"), whereby the Investor purchased a convertible promissory note in the initial principal amount of $217,391

View on SEC.gov

315 debt financings filed in the last 30 days. Browse all debt financings →

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001185185-25-001777

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.